- Joined
- May 6, 2009
- Messages
- 1,370
- Reaction score
- 1,132
Anyone ever heard of this?
I was about to give a bunch of oral vitamin K to an EtOHer with minimally functional liver the other day when an attending brought up a new reason to be cautious with vitamin K.
The attending stated that up to 10% of patients treated with oral vitamin K for warfarin-induced coagulopathy will subsequently become warfarin resistant.
Obviously this has nothing to do with the EtOHer's coagulopathy, but the attending was trying to get me to think about my use of oral vitamin K more. He said the risk-benefit analysis of this iatrogenic resistence must be especially considered in patients with metallic valves who are not actively bleeding but have an INR > 10.
I tried searching PubMed, but came up with very little...a line here and there, but not as much as I would expect for a potential complication affecting up to 10% of patients on coumadin.
Anyone ever heard of this?
HH
I was about to give a bunch of oral vitamin K to an EtOHer with minimally functional liver the other day when an attending brought up a new reason to be cautious with vitamin K.
The attending stated that up to 10% of patients treated with oral vitamin K for warfarin-induced coagulopathy will subsequently become warfarin resistant.
Obviously this has nothing to do with the EtOHer's coagulopathy, but the attending was trying to get me to think about my use of oral vitamin K more. He said the risk-benefit analysis of this iatrogenic resistence must be especially considered in patients with metallic valves who are not actively bleeding but have an INR > 10.
I tried searching PubMed, but came up with very little...a line here and there, but not as much as I would expect for a potential complication affecting up to 10% of patients on coumadin.
Anyone ever heard of this?
HH